MedPath
NMPA Approval

Parecoxib Sodium for Injection

国药准字H20223841

November 15, 2022

Drug Information

注射用帕瑞昔布钠

注射剂

40mg(按C₁₉H₁₈N₂O₄S计)

化学药品

November 15, 2022

Company Information

Applicant Company

武汉经济技术开发区海特科技园

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用帕瑞昔布钠 - NMPA 批准文号 | MedPath